Market Overview:
The global acute gastritis treatment market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The growth in the market can be attributed to the increasing incidence of gastritis, rising awareness about various treatment options available for gastritis, and growing demand for minimally invasive procedures. However, the high cost of advanced treatments and lack of reimbursement policies are restraining the growth of this market. The global acute gastritis treatment market is segmented on the basis of type, application, and region. On the basis of type, it is divided into antacids, antibiotics, painkillers, and others. Antibiotics are further sub-segmented into proton pump inhibitors (PPIs), H2 blockers (H2Bs), histamine receptor antagonists (H2RAs), and miscellaneous antibiotics. On the basis of application, it is classified into virus infection Gastroesophageal reflux disease (GERD), irritant gastroenteritis caused by food or chemicals ingestion,, drug-induced vomiting or nausea,, stress ulceration,, Zollinger-Ellison syndrome,, Helicobacter pylori infection,, other applications,. Geographically speaking North America dominates this market followed by Europe due to better reimbursement scenario in these regions as compared to Asia Pacific region which accounts for majority share in terms revenue generated from this therapy area.
Product Definition:
Acute Gastritis Treatment is a medical treatment used to cure or relieve the symptoms of acute gastritis. Acute gastritis is a condition that results in inflammation of the stomach lining. Symptoms of acute gastritis may include nausea, vomiting, abdominal pain, and diarrhea. Treatment for acute gastritis typically includes antibiotics to kill any bacteria that may be causing the inflammation, as well as medications to reduce nausea and vomiting.
Antacids:
Antacids are generally used for treating heartburn or acid indigestion. They neutralize the stomach acids and thus relieve the symptoms of heartburn. Antacids can be administered in two ways; as a prescription drug or over-the-counter (OTC) product. The most common type of antacid is aluminum hydroxide gel, which is sold under various brand names including Alka Seltzer, Prilosec, and Nexium among others.
Antibiotic:
Antibiotics Market Size, Share & Trends Analysis Report By Product (Bacteriostatic, Bactericidal), By Application (Gastroenterology, Urology), And Segment Forecasts, 2019 - 2026 -> The global antibiotic and its usage in acute gastritis treatment market size was valued at USD 2.5 billion in 2018 and is expected to grow at a compound annual growth rate (CAGR) of 3.0% from 2019 to 2026.
Application Insights:
Based on application, the global acute gastritis treatment market is segmented into virus infection, irritant and drug stimulate, other conditions and drugs that cause gastritis. The other conditions include chronic idiopathic constipation (CIC) as well as Crohn¢â‚¬â„¢s disease. Acute viral gastroenteritis is anticipated to be the fastest-growing segment over the forecast period owing to increasing healthcare spending by governments across various countries including U.S., China, India and Brazil in order to control rising cases of diarrhea among infants & children caused by viruses such as rotavirus or norovirus.
The irritant category includes acid reflux associated with smoking or drinking too much alcohol which causes heartburn or burning sensation in epigastrium region after meals.
Regional Analysis:
North America dominated the global market in 2017 owing to the presence of key players, such as Pfizer Inc.; GlaxoSmithKline plc; and Merck & Co., Inc. Moreover, rising prevalence of gastritis is also one of the major factors contributing to regional growth. For instance, according to a study published by National Institutes of Health (NIH), in U.S., approximately 15% population above 20 years old suffers from acute gastritis at least once per year.
Asia Pacific region is expected to witness lucrative growth over the forecast period due to rise in disposable income and improved healthcare facilities coupled with growing awareness about available treatment options among patients suffering from acute gastritis attacks.
Growth Factors:
- Increasing incidence of gastritis across the globe
- Rising awareness about the available treatment options for acute gastritis
- Growing demand for effective and safe treatments for acute gastritis
- Technological advancements in the field of acute gastritis treatment
- Availability of affordable and accessible treatments for acute gastritis
Scope Of The Report
Report Attributes
Report Details
Report Title
Acute Gastritis Treatment Market Research Report
By Type
Antacids, Antibiotic, Painkiller, Others
By Application
Virus Infection, Irritant, Drug Stimulate, Others
By Companies
Wuhan Senwayer Century, Hangzhou Vega, Katsura Chemical, SAURAV CHEMICALS, Alchem International, ROLABO OUTSOURCING, RESONANCE LABORATORIES, Lupin Ltd, AstraZeneca, Microbiotix, Cipla, Perrigo Pharmaceutical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
123
Number of Tables & Figures
87
Customization Available
Yes, the report can be customized as per your need.
Global Acute Gastritis Treatment Market Report Segments:
The global Acute Gastritis Treatment market is segmented on the basis of:
Types
Antacids, Antibiotic, Painkiller, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Virus Infection, Irritant, Drug Stimulate, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Wuhan Senwayer Century
- Hangzhou Vega
- Katsura Chemical
- SAURAV CHEMICALS
- Alchem International
- ROLABO OUTSOURCING
- RESONANCE LABORATORIES
- Lupin Ltd
- AstraZeneca
- Microbiotix
- Cipla
- Perrigo Pharmaceutical
Highlights of The Acute Gastritis Treatment Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Antacids
- Antibiotic
- Painkiller
- Others
- By Application:
- Virus Infection
- Irritant
- Drug Stimulate
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Acute Gastritis Treatment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Acute gastritis is a condition that results when the stomach lining becomes inflamed. This can happen for many reasons, including eating foods that are high in acid (such as tomatoes or citrus fruits). Treatment typically involves taking over-the-counter medications and drinking fluids to relieve the pain and inflammation. In some cases, surgery may be necessary to remove part of the stomach lining.
Some of the key players operating in the acute gastritis treatment market are Wuhan Senwayer Century, Hangzhou Vega, Katsura Chemical, SAURAV CHEMICALS, Alchem International, ROLABO OUTSOURCING, RESONANCE LABORATORIES, Lupin Ltd, AstraZeneca, Microbiotix, Cipla, Perrigo Pharmaceutical.
The acute gastritis treatment market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Acute Gastritis Treatment Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Acute Gastritis Treatment Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Acute Gastritis Treatment Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Acute Gastritis Treatment Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Acute Gastritis Treatment Market Size & Forecast, 2020-2028
4.5.1 Acute Gastritis Treatment Market Size and Y-o-Y Growth
4.5.2 Acute Gastritis Treatment Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Antacids
5.2.2 Antibiotic
5.2.3 Painkiller
5.2.4 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Virus Infection
6.2.2 Irritant
6.2.3 Drug Stimulate
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Acute Gastritis Treatment Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Acute Gastritis Treatment Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Antacids
9.6.2 Antibiotic
9.6.3 Painkiller
9.6.4 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Virus Infection
9.10.2 Irritant
9.10.3 Drug Stimulate
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Antacids
10.6.2 Antibiotic
10.6.3 Painkiller
10.6.4 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Virus Infection
10.10.2 Irritant
10.10.3 Drug Stimulate
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Antacids
11.6.2 Antibiotic
11.6.3 Painkiller
11.6.4 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Virus Infection
11.10.2 Irritant
11.10.3 Drug Stimulate
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Antacids
12.6.2 Antibiotic
12.6.3 Painkiller
12.6.4 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Virus Infection
12.10.2 Irritant
12.10.3 Drug Stimulate
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Antacids
13.6.2 Antibiotic
13.6.3 Painkiller
13.6.4 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Virus Infection
13.10.2 Irritant
13.10.3 Drug Stimulate
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Acute Gastritis Treatment Market: Competitive Dashboard
14.2 Global Acute Gastritis Treatment Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Wuhan Senwayer Century
14.3.2 Hangzhou Vega
14.3.3 Katsura Chemical
14.3.4 SAURAV CHEMICALS
14.3.5 Alchem International
14.3.6 ROLABO OUTSOURCING
14.3.7 RESONANCE LABORATORIES
14.3.8 Lupin Ltd
14.3.9 AstraZeneca
14.3.10 Microbiotix
14.3.11 Cipla
14.3.12 Perrigo Pharmaceutical
